CLINICAL_TRIALS
trial_result
· 2015-06-11
Clinical Trial Update: Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma [Phase 2]
Summary
Phase 2 study evaluating ipilimumab plus dacarbazine in Japanese patients with advanced melanoma; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2015-06-11